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Although it is known that Ad5-speciﬁc neutralizing antibodies (NAbs) against three major viral capsid
components (hexon, penton and ﬁber) are generated, differences in the frequency and nature of these
pre-existing NAbs remain unclear. The results emphasized the contribution of anti-ﬁber antibodies to
Ad5 neutralization responses generated during natural viral infection. Additionally, Ad5-speciﬁc NAbs
against the ﬁber knob protein were present in over 90% of the positive serum samples while 42% of the
sera had NAbs against hexon in this study based on neutralization assay of anti-HVR and anti-knob
subtracted sera and Western blotting analysis. We also found that the trimeric knob was preferentially
recognized by ﬁber-induced NAbs and it was serotype-speciﬁc in human adenovirus species C. Results
indicated that the trimeric knob protein would be a good candidate antigen for detecting adenovirus
serotype-speciﬁc NAbs in naturally infected sera.
& 2013 Elsevier Inc. All rights reserved.Introduction
Adenoviruses (Ads) are non-enveloped DNA viruses that have
been extensively studied and used as vectors for vaccine and gene
delivery. A limitation that has become apparent with the most
well-studied adenovirus type 5 (Ad5) vaccine vector is the high
titers of naturally occurring Ad5 neutralizing antibodies (NAbs)
in human populations, particularly in the developing world
(Yu et al., 2012b).
There are three major capsid proteins on Ad particles: ﬁber,
penton base and hexon. Both the ﬁber and hexon proteins contain
group-speciﬁc as well as type-speciﬁc epitopes (Norrby, 1969;
Rux and Burnett, 2000). Previous studies have reported that ﬁber-
and penton-speciﬁc antibodies against Ad5 exert synergistic
neutralizing activities, which are functionally signiﬁcant, and
Ad5-speciﬁc NAbs directed against the Ad5 hexon protein are
found in both humans and mice (Gahery-Segard et al., 1998;
Sumida et al., 2005). It is clear from these studies that Ad5-
speciﬁc NAbs against multiple capsid components are generated.
Interestingly, recent studies have emphasized that the speciﬁcity
of Ad5 NAbs is directed towards hexon and ﬁber, but it is unclearll rights reserved.
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ular; IN, intranasal
e, Jilin University, No. 2699
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xianghui@jlu.edu.cn (X. Yu).which protein is dominant in the NAb response and whether the
route of exposure (e.g., natural infection versus rAd5 vaccination)
may lead to a difference between the humoral immune response
to these two proteins (Bradley et al., 2012; Cheng et al., 2009).
Clarify the characteristics of NAbs to adenovirus capsid proteins
in human and animal sera will help to design the novel chimeric
Ad5 vectors evaded Ad5-speciﬁc NAbs.
Currently, 57 human Ad serotypes are deﬁned and distri-
buted into seven species from A to G (Walsh et al., 2011).
Infection-induced humoral immunity to a particular serotype
does not provide cross-immunity to an Ad serotype of another
subgroup (Hierholzer et al., 1991). Serotype-speciﬁc NAbs are
detected by viral vector-based neutralization assays (NA) and
have been used in epidemiological studies on the prevalence of
pre-existing NAbs to several conceptually interesting vaccine
vector candidate types (Mast et al., 2010). Although neutralization
assays are efﬁcient means for detecting speciﬁc antibodies
against each Ad serotype, they are cumbersome and expensive
to perform. Therefore, more simple typing methods for NAbs are
needed.
In this study, we demonstrated that NAbs against ﬁber are
commonly generated in natural adenovirus infection in humans
and rAd immunization in animals. We also showed that
the trimeric knob protein was speciﬁcally recognized by Ad NAbs
in species C, rendering it would a good candidate antigen to
detect serotype-speciﬁc NAbs in natural Ad infection and rAd
vaccination.
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Analysis of capsid-speciﬁc humoral immune response in human sera
from natural Ad infection
Human serum samples were analyzed at different titers
(o200, 201–1000, 41000) by Western blotting to determine
whether immune responses to the three major components
(hexon, penton and ﬁber) of the viral capsid in the sera correlated
with the titers calculated using previous methods (Abbink et al.,
2007; Yu et al., 2012b). As shown in Fig. 1A, higher serum titers
corresponded to increased antigen–antibody responses, and vice
versa. Substantially higher levels of anti-penton and anti-ﬁber
antibodies were detected than anti-hexon antibodies in subjects
with natural Ad infection (titero1000) in our study. However,
antibodies to Ad5 in some high titered (41000) samples were
also partly against the hexon protein. To precisely identify the
anti-ﬁber and anti-hexon antibody responses in human sera, the
recombinant Ad5 knob domains of the ﬁber protein and the
complete peptide including all seven short HVRs on the surface
of the Ad5 hexon protein were used in Western blotting analysis.
The results showed that anti-ﬁber antibodies and anti-hexon
antibodies from the seropositive sera weakly recognized the
monomeric form of the knob (22 kDa) and HVR (40 kDa) proteins.
We also showed that both anti-ﬁber and anti-hexon antibodiesFig. 1. Capsid-speciﬁc humoral immune responses in human sera after natural Ad infection. (A) A
or high (titer41000) anti-Ad5 antibodies were analyzed byWestern blotting recognizing pur
adenovirus type 5 antibody (Abcam, Cambridge, UK), was a positive control. (B) Sera with hi
SDS-denatured Western blotting as described in Materials and methods. Ad negative sera w
(knob) antibodies contained in 149 human sera with baseline NAb titers were analyzed byW
sera. Different concentration of knob proteins were mixed with anti-Ad5 serum and incubat
means serummixed with different concentration of the proteins (1 unit¼1 mg/ml). (E) NAb
knob proteins detected. S¼serum; SK¼serum after incubation with knob; SH¼serum a
nnn¼po0.0001, nn¼po0.001 and n¼po0.05.from the sera preferentially recognized the native form of the
knob (66 kDa) and HVR (over 700 kDa) proteins (Fig. 1B).
To analyze the natural frequency of immune responses to ﬁber
and hexon proteins in sera with natural Ad5 infection, a total of
149 human serum samples with moderate and high NAb titers
(4200) were analyzed by virus or native protein-based Western
blotting. Fig. 1C shows that 98% of the sera had ﬁber-speciﬁc
antibodies, and 93% of the sera (including nearly all of the sera
with the ﬁber-speciﬁc band) speciﬁcally recognized the native
knob protein. In contrast, 48% and 42% of the sera had a hexon-
speciﬁc band and reacted with native HVR protein, respectively.
The results indicated that over 90% of the positive human sera
had anti-ﬁber antibodies and could also detect the native knob
protein in our study. To characterize the nature of the antibodies
induced by the capsid proteins in human sera of different titers,
the sera diluted 1:100 were partially depleted of anti-ﬁber and
anti-hexon antibodies by incubation with knob and HVR proteins.
The results showed that less of the neutralizing activity was
depleted by knob (po0.05) in all tested sera, while a larger part
of the serum neutralizing activity was depleted by HVR
(po0.001) in sera with anti-hexon antibodies, especially those
with high titer NAbs (titer41000) (Fig. 1D and E). These results
indicated that NAbs against ﬁber are commonly generated in
natural adenovirus infection in humans, although the neutralizing
activity detected by the knob was weak.d5 positive sera from participants with low (titero200), moderate (200otitero1000)
iﬁed rAd5. Bands corresponding to hexon, penton and ﬁber are indicated. Ab6982, anti-
gh titer anti-Ad5 antibodies were assessed against HVR and knob proteins by native or
ere used as negative control (con). (C) Percentages of anti-hexon (HVR) and anti-ﬁber
estern blotting as in (A) and (B). (D) Ad5 neutralization activity of anti-knob subtracted
ed with cells before the addition of rAd5. S¼human positive serum, Sþ5/10/25/50/100
titers of human sera cleared of selected antibodies by pre-incubation with HVR and (or)
fter incubation with HVR; SKH¼serum after incubation with both knob and HVR.
B. Yu et al. / Virology 437 (2013) 118–123120Analysis of capsid-speciﬁc humoral immune responses in mouse
and rabbit sera
To analyze the humoral immune responses to Ad5 capsid
proteins in animal sera, rabbit and BALB/c mice were immunized
using different rAd5 immunization protocols. One and two
immunizations in rabbits or IM and IN immunizations in mice
showed different immune responses from that with human
natural infection in that antibodies to Ad5 were directed mainly
to the hexon and ﬁber proteins and seldom to the penton protein
(Fig. 2A). Moreover, results of the Ad5 neutralization assay with
anti-HVR and anti-knob depleted sera were in good agreement
with the viral capsid protein immune responses and indicated
that NAbs to these two proteins accounted for most of the
neutralization activity in the immune sera (po0.0001) (Fig. 2B).
Interestingly, Western blotting analysis showed that only sera
from IM immunized mice had Ad5 NAbs which could bind with
trimeric knob proteins, while sera of IN immunized mice were
negative for Ad5 NAbs, although similar patterns of antibody
speciﬁc to Ad5 were observed in sera of IM and IN inoculated
mice. These results indicated that the trimeric knob was prefer-
entially recognized by ﬁber-induced NAbs (Fig. 2C and D).Trimeric knob proteins could induce and were recognized
by serotype-speciﬁc NAb
Since NAbs induced by different Ad serotypes did not show
cross-immunity, trimeric knob proteins of Ad2 and Ad5 within
human adenovirus species C (HAdV-C; Ad1, 2, 5 and 6) were
expressed as His-tagged fusion proteins in Escherichia coli to
analyze that if the trimeric knob protein can serve as an antigen
for distinguishing serotype speciﬁc responses. As shown inFig. 2. Capsid-speciﬁc humoral immune responses in mouse and rabbit sera after Ad5 imm
Western blotting. Left: lane 1, after one immunization; lane 2, after two immunizations
titers of rabbit and mouse serum after incubation with HVR and (or) knob proteins det
were assessed with knob protein by SDS-denatured or NDS Western blotting. Lanes 1 a
detected by neutralization assays.Fig. 3A, after immunization in rabbits with the puriﬁed trimeric
proteins, NAbs against adenoviruses were found in the hyper-
immune sera and showed no cross-neutralization between the
two rAd types (rAd2 and rAd5) tested in our study. These results
indicated that trimeric knob proteins could induce serotype-
speciﬁc Ad NAbs.
Based on human natural viral infection sera against Ad2 and
Ad5, no cross-immunity of the sera was observed by reactivity
with trimeric knob antigens in Western blotting assays. However,
weak cross-reactivity of the monomeric knob proteins was shown
with the human sera (Fig. 3B).Discussion
Ads are the cause of common upper respiratory infections, and
thus most individuals have circulating antibodies to these viruses.
Pre-existing immunity to Ad is an important issue in clinical trials
with rAd5 vector-based vaccines for HIV-1 and other pathogens
as it can limit in vivo delivery of Ad vectors and gene transfer
(Hong et al., 2003). Thus, understanding the nature of anti-Ad5
immunity and mapping the targets of dominant Ad5-speciﬁc
NAbs in human sera is important for the development of vaccines
against HIV-1 and other infections or diseases. In this study, we
examined in detail the Ad5-speciﬁc humoral immune response in
healthy humans by natural infection and in mice and rabbits with
rAd5 immunizations. These results conﬁrm and extend the ﬁnd-
ings of previous studies showing that antibodies generated by
natural infection in individuals are directed primarily to ﬁber and
penton components and not to hexon or HVR antigens (Hong
et al., 2003). However, antibodies to Ad5 in some high titered
(41000) NAb samples were also directed largely to the hexonunization. (A) Anti-Ad5 antibodies in rabbit and mouse serum were analyzed by
. Right: M, prestained protein marker; IM: intra-muscular; IN: intra-nasal. (B) NAb
ected by neutralization assays. (C) Mouse serum after IM or IN Ad5 immunization
nd 3, SDS-PAGE; lanes 2 and 4, NDS-PAGE and (D) Ad5 NAb titers of mouse serum
Fig. 3. Trimeric knob proteins could induce and were recognized by serotype-speciﬁc NAb. (A) Ad NAbs induced by knob proteins were determined by luciferase-based rAd2
and rAd5 neutralization assays. Anti-K2, 5 represent polyclonal anti-knob sera and (B) Reactivity of human anti-Ad2 and anti-Ad5 serum with knob antigens was analyzed
by SDS-denatured and NDS Western blotting.
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to be present in most of the seropositive samples and appeared to
be functionally relevant, although secondary in nature to NAbs
against HVR when anti-hexon antibodies were present. This result
may reﬂect differences in the exposure to ﬁber and hexon
antigens during natural infection. First, a mild Ad infection
commonly generates antibodies against ﬁber and penton anti-
gens, while severe and repeated infections over a short period
induce antibodies directed largely to the hexon protein. In
contrast to the immune responses with natural infection in
humans, rAd5 immunizations either in rabbits or mice resulted
in antibodies to Ad5 that were directed mainly to the hexon and
ﬁber proteins with few responses to the penton antigen. More-
over, Ad5-speciﬁc NAbs were directed primarily against the HVRs
and relatively weak against the knob domain. This observation
may explain why the hexon HVR chimeric rAd5 vectors can
circumvent pre-existing anti-vector immunity in mice with high
titer NAbs induced by Ad5 immunization (Roberts et al., 2006).
The results emphasized the contribution of anti-ﬁber antibo-
dies to neutralizing activity generated by natural viral exposure
and Ad immunization. Prior studies have demonstrated a direct
correlation between the capacity of anti-ﬁber antibodies to
recognize the native trimeric form of the ﬁber protein and
recognition of the native trimeric knob protein, which contain
mainly species-speciﬁc epitopes (Bauer et al., 2005; Gahery-
Segard et al., 1998). This study showed that the NAbs induced
by ﬁber in rAd5 immunized mice preferentially recognized the
trimeric knob protein. We assumed that the knob protein from
different Ad serotypes would speciﬁcally recognize NAbs of the
same Ad serotype since NAbs induced by different adenovirus
serotypes commonly show no cross-immunity, although some
previous studies have concluded that knob mainly contains
species-speciﬁc epitopes (Bauer et al., 2005; Havenga et al.,
2002; Liebermann et al., 2002). In fact, in a crystal structure
model, some important features such as valleys formed by the R-
sheets and the HI loops were found on the surface of the Ad5 knob
protein (Xia et al., 1994). Therefore, type-speciﬁc epitopes may be
located in highly variable regions on the surface of the knob
domain, and several type-speciﬁc antigenic epitopes on knob can
be identiﬁed by ELISA and other methods (Fender et al., 1995;
Liebermann et al., 2001; Liebermann, Lotz, and Seidel, 2002). To
verify our hypothesis, we expressed two knob proteins from
HAdV-C in E. coli and found that the trimeric knob protein could
induce serotype-speciﬁc Ad NAbs in rabbits and mice, which were
different from those found in humans induced by rAd5 immuni-
zation (Gahery-Segard et al., 1998). This difference may result
from the different antigens or immune response to Ad in humanand in animal body, as our results shown that almost no antibody
was produced against penton after Ad5 immunization in mice and
rabbits. The pattern of reactivity of the human sera indicated no
cross-immunity against trimeric knob proteins of the HAdV-C
species. By comparing with the corresponding amino acid
sequences from selected serotypes, we proposed that neutralizing
epitopes were located in the region that may be more limited,
such as LSSMTGTV (445–452) in many Ad2 ﬁber epitopes, and
that the trimeric form of knob was necessary for the recognition
to NAbs (Fender et al., 1995; Liebermann et al., 2002).
Of the more than 50 human adenovirus serotypes occurring
worldwide, the most commonly used rAd vector is Ad5; how-
ever, considering its high seroprevalence in the human popula-
tion, other serotypes are being investigated. The evaluation of
serotype-speciﬁc NAbs as a means of selecting the adequate
serotype adenovector(s) is important for both clinical applications
and epidemiological studies (Piedra et al., 1998; Sanchez et al.,
2001). Currently, the quantitative neutralization assay based on
rAds carrying luciferase or secreted alkaline phosphatase (SEAP)
reporter gene with the inhibition of transgene expression as a
readout is used to determine type-speciﬁc NAb titers (Aste-
Amezaga et al., 2004; Sprangers et al., 2003). Recent international
epidemiological studies of several Ad serotypes were carried out
using this method due to its good accuracy and sensitivity (Mast
et al., 2010). However, the lower replication and difﬁcult con-
struction of some rAds will limit the application of this method
for additional Ad serotypes. In this study, we suggested that
trimeric ﬁber knob may be a good candidate antigen to detect
serotype-speciﬁc NAbs, although more knob proteins from other
Ad serotypes need to be detected the cross-immunity with the
sera raised against Ads in different human adenovirus species.
In conclusion, this study highlights the contribution of anti-
ﬁber antibodies to neutralization generated by natural infection.
Furthermore, we have shown that the trimeric knob might be
used to test the prevalence of several Ad serotypes.Materials and methods
Cell lines and serum
Human embryonic kidney (HEK) 293 and human lung epithe-
lial A549 cells were obtained from the American Type Culture
Collection (ATCC; Manassas, VA). All cells were cultured in
Dulbecco’s Modiﬁed Eagle’s Medium (DMEM; Invitrogen, Carlsbad,
CA) containing 10% fetal bovine serum, (FBS; Hyclone; Logan, UT),
B. Yu et al. / Virology 437 (2013) 118–1231222 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomy-
cin (Invitrogen).
Recombinant ad antigens
The sequence of Ad knob including the last shaft of the ﬁber
(Yeh et al., 1994) was cloned into the pRSET-B plasmid (Invitro-
gen) at the Nco I and Xho I restriction sites. The plasmid contain-
ing an N-terminal His tag was expressed in BL21 cells overnight at
16 1C. The pellet from a 2-l culture was treated with 1 mg of
lysozyme/ml on ice and sonicated 10 times for 10 s each time.
After centrifugation at 40,000g for 30 min, 10 mM imidazole was
added to the soluble fraction at 4 1C with gentle stirring. The resin
was ﬁlled in a small polyethylene column and washed with
20 mM imidazole in a buffer containing 25 mM Tris–HCl (pH
7.5) and 150 mM NaCl. The protein was eluted with 500 mM
imidazole in the same buffer and analyzed by SDS-PAGE. The Ad5
hexon hypervariable regions (HVRs) protein was expressed as our
described previously (Yu et al., 2012a).
Mice and immunizations
Six- to eight-week-old BALB/c mice were given two intramus-
cular (IM) injections, separated by a 4-week interval, with
11010 viral particles (vp) of replication incompetent rAd5-
blank vectors in 100 ml of sterile PBS divided equally between
both quadriceps muscles. For intranasal (IN) inoculation, 5 ml
rAd5-blank (5109 vp) was instilled in both nostrils of each
animal using a micropipette tip. Five mice were used in each
group and the serum used for the Western blotting and neutra-
lization assay was pooled from all the 5 mice. All animal studies
were approved by University Committee on the Use and Care of
Animals of Jilin University.
Human serum
Human serum samples were collected randomly in 2010–2011
in China by the Provincial Centers for Disease Control and
Prevention. Donors were aged from 18 to 60 years old of both
sexes, with no history of any febrile illness during the few weeks
preceding sample collection. Informed consent was obtained from
all participants and the serum samples utilized in adenovirus
neutralization assays were approved by the Human Ethical
Committee Institutional Review Board, Jilin University, China.
Virus neutralization assays
Ad-speciﬁc NAb titers in human serum samples were assessed
by luciferase-based assays as described previously (Sprangers
et al., 2003). HEK293 cells were plated at a density of 1104
cells per well in 96-well plates and infected with replication-
incompetent rAd-Luc reporter constructs at a multiplicity of
infection (MOI) of 500 with 2-fold serial dilutions of serum in
200 ml reaction volumes. Following a 24-h incubation, luciferase
activity in the cells was measured using the Steady-Glo Luc
reagent system (Promega, Madison, WI) with a Victor 1420
ultilabel counter (Perkin Elmer, Wellesley, MA). Neutralization
titers were deﬁned as the maximum serum dilution that inhibited
90% of luciferase activity.
Ad5 neutralization assay of anti-HVR or anti-knob subtracted sera
HEK293 cells were plated at a density of 1104 cells per well
in 96-well plates and incubated for 24 h at 37 1C and 5% CO2. The
following day, 50 mg/ml HVR or knob proteins were incubated
with serially diluted Ad5-seropositive sera for 2 h at 37 1C in100 ml reaction volumes. Next, 50 ml of 5% nickel nitrilotriacetic
acid (Ni-NTA) beads suspension (Invitrogen, Carlsbad, CA) were
added and incubated for 1 h with gently shaking at room
temperature before centrifugation at 12,000 rpm for 5 min to
remove the proteins and protein–antibody complexes as the knob
proteins would block the infection of rAd5 in 293 cells. A ﬁxed
amount of rAd5-Luc was then incubated for 1 h at 37 1C either
with no serum and removal of protein solution, corresponding to
100% luciferase activity, or with the serum solution after removal
of protein–antibody complexes. As another positive control, virus
only with serially diluted serum was added to cells, and as a
negative control, cells were cultured in the absence of virus.
Following 24 h of incubation, luciferase activity in the cells was
measured as for the neutralization assays above.
Western blotting analysis
Protein samples were electrophoresed by SDS-PAGE, NDS-
PAGE or Native-PAGE as described previously (Yu et al., 2012a),
and transferred to nitrocellulose membranes for Western blotting.
SDS was not added into the transfer buffer (39 mM glycine,
48 mM Tris–HCl, 20% methanol, pH 9.2) when proteins were
separated by Native-PAGE. Membranes were incubated with
different human, rabbit and mouse sera overnight at 4 1C in PBS
containing 1.0% milk and then subsequently incubated with
ImmunoPure alkaline phosphatase-conjugated goat anti-rabbit
IgG secondary Abs (Jackson ImmunoResearch Laboratories, Inc.)
at a 1/10,000 dilution for 1 h. The color reaction was developed
with 0.1 M Tris–HCl (0.1 M NaCl, 5 mM MgCl2, pH 9.5) containing
0.66% NBT solution and 0.33% BCIP solution.
Statistical analysis
Values are expressed as means7SEM. Differences between
groups were examined by Student’s t-test (signiﬁcant when
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